Affiliations 

  • 1 International Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, 44150, Thailand
  • 2 Clinical Trials and Evidence-Based Syntheses Research Unit (CTEBs RU), Department of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, Thailand
  • 3 School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Selangor, Malaysia
  • 4 Faculty of Pharmacy, Sanata Dharma University, Yogyakarta, Indonesia
  • 5 Faculty of Pharmaceutical Science, Chulalongkorn University, Bangkok, Thailand
  • 6 Faculty of Pharmacy, Phenikaa University, Ha Dong, Hanoi, Vietnam
  • 7 Faculty of Pharmacy, University of Health Sciences, Vientiane Capital, Lao PDR
  • 8 PAP Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam (UBD), Jalan Tungku Link Gadong, Bandar Seri Begawan, Brunei
  • 9 Business School, Mahasarakham University, Maha Sarakham, Thailand
  • 10 Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, Alabama, USA
  • 11 Faculty of Pharmacy, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam
  • 12 International Primary Care Practice Research Unit (iPCPRU), Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, 44150, Thailand. chanuttha.p@msu.ac.th
Sci Rep, 2025 Nov 20;15(1):40930.
PMID: 41266400 DOI: 10.1038/s41598-025-24749-3

Abstract

Noncommunicable diseases (NCDs) are the leading cause of morbidity and mortality in ASEAN countries. However, consolidated evidence regarding the effectiveness of pharmacy practice interventions in ASEAN is still unclear. This study aimed to explore the scope and impact of pharmacy practice in managing NCDs in ASEAN countries. Systematic searches were conducted in 12 databases (PubMed™, Science Direct™, Scopus™, Springer Link™, Web of Science™, Cochrane Library™, and other databases) for studies published between 2001 and 2021. Of the 171 included studies from seven countries, seven focused on pharmacy education and showed improvements in students' knowledge and skills. Meta-analyses were performed on 47 randomized controlled trials using a random-effects models and risk of bias assessment. Pharmacists' interventions significantly improved fasting blood glucose, HbA1c, lipid parameters, blood pressure, and percent peak expiratory flow rates, compared to usual care. No significant improvements were found in blood pressure (particularly in diabetes subgroups), smoking cessation, or body weight. Positive humanistic outcomes, such as patient satisfaction, knowledge, and quality of life, were reported. While the studies in the meta-analyses were limited to Thailand, Malaysia, Indonesia, and Lao PDR, pharmacists' practice interventions in ASEAN countries demonstrated positive impacts on both clinical and humanistic outcomes. Due to a high overall risk of bias, the results should be interpreted with considerable caution. Further large-scale, long-term, and rigorous studies should be undertaken.Systematic review registration: The Prospective Registration of Systematic Review on April 10, 2022, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=316184 .

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.